Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Merrimack Pharmaceuticals Q2 EPS $(0.06) Up From $(0.09) YoY

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.06) per share. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year.

byBenzinga Newsdesk

August 5, 2021

1 minute read

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly losses of $(0.06) per share. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year.